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ABSTRACT
Background and Objectives: Morning hypertension is closely related to target organ damage and cardiovascular events. 
Little data is available concerning the baseline characteristics and comprehensive blood pressure analysis of hypertensive 
patients on treatment with morning hypertension. Subjects and Methods: We evaluated 1,087 hypertensive patients who 
had taken stable anti-hypertensive medication at least 6 months. The enrolled patients measured their home blood pressure 
for 7 days. Baseline characteristics and the laboratory data were analyzed. Morning hypertension was defined as a morning 
blood pressure ≥135/85 mm Hg and systolic or diastolic blood pressure difference between morning and evening exceeding 
10 mm Hg. Results: One hundred seventy three patients with morning hypertension showed a preponderance of males, 
older patients, alcohol consumers, and greater waist circumference and waist-to-hip ratio despite the same body mass index. Im-
paired fasting glucose and metabolic syndrome were more prevalent in the patients with morning hypertension. The morn-
ing hypertensives took more anti-hypertensive drugs and displayed higher blood pressure in the clinic and at home. Conclu-
sion: The worse clinical variables and relatively poorly controlled blood pressure of those with morning hypertension supports 
a potential relationship of morning hypertension with poor cardiovascular outcome. Morning blood pressure should be moni-
tored at home for the optimal treatment of hypertension. (Korean Circ J 2011;41:733-743)
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Introduction 
Critical cardiovascular events frequently occur in the morn-
ing, especially just after awakening. This phenomenon is clo-
sely related with the circadian variation of blood pressure (BP) 
and the excessive elevation of BP in the morning.
1)2) Numer-
ous reports have advocated that this so-called morning hy-
pertension (MH) is closely related to target organ damage 
and the risk of cardiovascular events.
3-14)
While the prognostic value of MH is very well-known, lit-
tle is known about the baseline characteristics of those who 
experience MH and its clinical implications. Old age, male 
gender, regular consumption of alcohol, more pronounce use 
of diverse types of antihypertensive drugs, greater use of be-
ta-blockers and higher BP measured at the clinic were major 
determinants of the difference in BP between morning and 734   Morning Hypertension
evening in the Jichi Morning Hypertension Research study, 
in which BP was self-measured at home.
15)16) Older age, male 
preponderance, regular alcohol consumption and BP mea-
surement after bathing at night have been suggested as im-
portant determinants of the exaggerated difference in morn-
ing and evening home BP.
17) Patients with metabolic syndrome 
have a higher prevalence of MH.
18) Another study using ambu-
latory blood pressure monitoring showed that morning BP 
surge was associated with old age, elevated fasting plasma glu-
cose and higher 24-hour systolic BP.
19) 
Comprehensive analysis of BP profiles in MH patients has 
rarely been done and the relationship between MH and other 
abnormal home BP categories, such as masked hypertension 
or uncontrolled hypertension, is still unclear. To address these 
knowledge shortfalls, the present cross-sectional and obser-
vational study was performed in a multi-center manner. The 
study aimed to evaluate the baseline characteristics of the 
patients with MH and to analyze their office and home BP 
profiles. The goal was to ascertain whether MH could be a new 
target in the treatment of hypertension. 
Subjects and Methods 
Study population
The protocol of this cross-sectional, observational study 
was approved by the Institutional Review Boards of the par-
ticipating institutions. We evaluated 1,087 hypertensive pa-
tients >18-years-of-age using self-measured home BP in the 
morning and evening. The patients were recruited from nine 
university hospitals in Korea that are part of the Hyperten-
sion Research Network. Participants had maintained stable 
anti-hypertensive medications at least for the previous 6 
months. Clinical information about the subjects (e.g., age, 
sex, body weight, height, waist circumference, hip circum-
ference, current medications, social, familial and past medical 
history) and laboratory data (e.g., C-reactive protein, lipid pro-
files, serum glucose and serum creatinine) were analyzed. 
Home BP measurements
Physicians and well-trained nurses educated the patients 
how to measure and record home BP. After verifying their 
home BP measuring capability, patients were asked to mea-
sure their own BP once in the morning and once in the even-
ing. The morning measurement was taken while in a sitting 
position, within 1 hour after awakening, before taking anti-
hypertensive medication, before breakfast meal and after 
more than 2 minutes of rest. The evening measurement was 
taken in a sitting position, 1 hour before going to bed and af-
ter more than 2 minutes of rest, as specified by the Japanese 
guidelines for home BP measurement.
20) Each subject was re-
quested to obtain two consecutive measurements; if the dif-
ference of those values exceeded 10 mm Hg, BP was checked 
again and the second and third values were analyzed. BPs 
and pulse rates were recorded for 7 days and all measure-
ments (≥20) were analyzed. The sphygmomanometer used in 
this study was a model HEM-747 cuff oscillometric device 
(Omron Healthcare, Kyoto, Japan). 
Office BP measurements
Office BP and pulse rate were measured twice consecutively 
by physicians while the subject was in a sitting position after 
at least 2 minutes of rest. The same cuff oscillometric device 
model used for the home measurements was used.
Definitions 
MH was defined as a morning-evening systolic or diastolic 
BP difference exceeding 10 mm Hg. Morning BP was defin-
ed as a pressure ≥135/85 mm Hg. In cases where systolic or 
diastolic BP was in a different category, the higher category 
was applied. Four potential groups were suggested based on 
hospital BP (140/90 mm Hg) and home BP (135/85 mm Hg) 
levels: controlled hypertension (no hypertension in hospital 
and at home), white-coat hypertension (hypertension in hos-
pital but not at home), masked hypertension (no hyperten-
sion in hospital but hypertension at home) and uncontrolled 
hypertension (hypertension in hospital and at home). White 
coat effect was defined as a difference of office and home BP. 
Optimal goal of BP control was considered to be <140/90 mm Hg 
in the office BP and <135/85 mm Hg in the home BP. In pa-
tients with diabetes mellitus (DM), the BP goal was <130/80 
mm Hg both in the office and at home. Metabolic syndrome 
was categorized according to National Cholesterol Education 
Program Adult Treatment Panel Guideline III criteria (for 
obesity, a waist circumference >90 cm in males and >80 cm 
in females).
Statistical analyses
We organized a registry from the demographic, laboratory 
data and the BP profiles of the enrolled patients. The variables 
were compared between the MH patients and the non-MH 
patients. Intergroup comparisons of the baseline demograph-
ics and the clinical characteristics were performed using χ2-
test, Fisher’s exact test, t-test and linear by linear association. 
BP profiles were analyzed with t-test and analysis of variance. 
A p<0.05 was considered statistically significant. All of the 
data were expressed as mean±standard deviation unless oth-
erwise stated. The software package Statistical Package for the 
Social Sciences (SPSS) 17.0 for Windows (SPSS, Chicago, IL, 
USA) was used for the statistical analyses.
Results 
Study patients
Hypertensive patients (n=1,087, mean age 56.9±9.6 years, Ju-Hee Lee, et al.   735
519 males) taking anti-hypertensive medication were evalu-
ated. One hundred seventy three patients (15.9%) met the 
definition of MH. The prevalence of controlled hypertension, 
white-coat hypertension, masked hypertension and uncon-
trolled hypertension was 38.2% (n=415), 23.5% (n=255), 
11.2% (n=122) and 27.1% (n=295), respectively. Mean office 
systolic/diastolic BP was 138.5±15.9/82.7±10.5 mm Hg and 
mean home systolic/diastolic BP was 130.1±13.9/81.0±9.7 
mm Hg in the morning and 127.3±13.5/77.4±9.7 mm Hg in 
the evening. The average home systolic/diastolic BP was 
128.7±12.8/79.2±9.2 mm Hg. One hundred seventy eight pa-
tients (16.3%) were diagnosed with DM and 512 patients 
(47.0%) were categorized with metabolic syndrome.
Baseline characteristics
The patients with MH were mainly male (56.6% vs. 46.1%, 
p=0.011), greater consumers of alcohol (49.7% vs. 35.9%, p= 
0.001) and had greater waist circumference (88.9±8.4 cm vs. 
87.3±8.4 cm, p=0.026) and waist-to-hip ratio (90.2±5.1% 
vs. 88.9±5.6%, p=0.004) despite having the same body mass 
index (BMI; 25.2±3.0 vs. 25.1±2.9, p=0.512). Laboratory data 
were comparable in the two groups. Patients with MH took 
Table 1. Baseline demographic and laboratory data of patients with or without morning hypertension
Patients with MH (n=173) Patients without MH (n=914) p
Male, n (%)  098 (56.6) 421 (46.1) 0.011
Age (years)  58.1±9.3 56.7±9.7 0.070
Body weight (kg)  0067.0±10.80 066.0±10.5 0.243
Height (cm)  162.7±0.10 162.0±0.10 0.278
BMI (kg/m
2)  25.2±3.0 25.1±3.0 0.512
Waist circumference (cm)  88.9±8.4 87.3±8.4 0.026
Waist to hip ratio (%)  90.2±5.1 88.9±5.6 0.004
Smoking, n (%)  028 (16.4) 125 (13.7) 0.364
    Pack years (PY)  005.2±12.8 004.0±18.9 0.455
Drinking alcohols, n (%)  086 (49.7) 328 (35.9) 0.001
    Drinking capacity (g/week)  0097.6±171.5 0046.5±105.7 <0.001
Diet, n (%) 0.952
    Not salty 039 (22.7) 198 (21.7)
    Moderately salty 087 (50.6) 482 (52.9)
    Salty 046 (26.7) 232 (25.4)
Physical inactivity, n (%)  061 (35.3) 330 (36.1) 0.824
Current anti-hypertensive medications, n (%) 
Angiotensin receptor blocker 094 (54.7) 463 (51.1) 0.393
ACE inhibitor 018 (10.5) 110 (12.1) 0.388
Alpha-adrenergic blocker 05 (2.9) 28 (3.1) 0.896
Beta-adrenergic blocker 074 (43.0) 323 (35.7) 0.066
Calcium channel blocker 119 (69.2) 594 (65.6) 0.367
Diuretics 053 (30.8) 258 (28.5) 0.535
Number of drugs 02.11±0.88 1.96±0.87 0.038
Laboratory data
Fasting blood glucose (mg/dL) 107.9±20.2 105.7±24.1 0.257
Serum creatinine (mg/dL)  01.0±0.2 01.0±0.4 0.447
Creatinine clearance (mL/min)  076.5±21.4 078.3±21.7 0.329
Estimated GFR (mL/min)  075.9±15.3 077.3±17.7 0.318
Total cholesterol (mg/dL)  181.0±33.7 180.7±35.4 0.939
Triglyceride (mg/dL)  144.3±80.8 138.1±77.1 0.358
LDL-C (mg/dL)  101.7±32.5 102.0±32.7 0.928
HDL-C (mg/dL)  051.3±12.9 051.7±13.1 0.738
Mean±SD. MH: morning hypertension, BMI: body mass index, GFR: glomerular filtration rate, LDL-C: low density lipoprotein-cholesterol, 
HDL-C: high density lipoprotein-cholesterol736   Morning Hypertension
more classes of antihypertensive drugs (2.11±0.88 vs. 1.96± 
0.87, p=0.038). There was no significant difference of overall 
drug use between two groups (Table 1).
Metabolic syndrome
Metabolic syndrome was more prevalent in all enrolled pa-
tients than in the general population (n=512; 47.0% in study 
participants vs. 24.1% in Korean general population
21)) and 
MH patients showed a higher prevalence of metabolic syn-
drome (59.5% vs. 49.5%, p=0.019) (Table 2). Laboratory data 
including fasting glucose and lipid profiles were comparable 
in the two groups and there was no difference in DM status 
(p=0.564). However, when impaired fasting glucose (IFG) 
was included, the composite of DM and IFG were more prev-
alent in the patients with MH (37.4% vs. 28.8%, p=0.024). MH 
patients had more metabolic components (p=0.049) (Fig. 1). 
Cardiovascular risk and target organ damage
There was no significant difference of major risk factors for 
cardiovascular disease in two groups except age (p=0.021) 
(Table 3). But, the number of major risk factors showed an in-
creasing tendency in the MH group (p=0.076). We evaluated 
the incidence of target organ damage related to hypertension. 
Target organ damages included left ventricular hypertrophy, 
angina, prior myocardial infarction, prior percutaneous cor-
onary intervention and heart failure in the cardiovascular sys-
tem, stroke and transient ischemic attack in cerebrovascular 
system, DM nephropathy and renal insufficiency (estimated 
glomerular filtration rate <60 mL/min, serum creatinine >1.5 
mg/dL in males and >1.3 mg/dL in females) and proteinuria 
>300 mg over 24 hours in the renal system. There was a tend-
ency of higher prevalence of target organ damage to kidney 
(p=0.068) in MH patients, but the prevalence of target organ 
damage in the cardiovascular and cerebrovascular systems 
was comparable in the two groups.
BP profiles of the patients with MH
There was a significant difference in the distribution of BP 
categories between the MH and non-MH groups. MH pa-
tients showed higher prevalence of uncontrolled hyperten-
sion and masked hypertension (51.4% and 15.6%, respec-
tively) compared with non-MH patients (22.5% and 10.4%, 
same respective order), while they showed lower prevalence 
of controlled hypertension (13.3% for MH vs. 42.9% for non-
MH) (Fig. 2A). MH comprised 5.5% of all controlled hyper-
tension and 13.3%, 23.1% and 30.2% of white-coat, masked 
and uncontrolled hypertension, respectively (Fig. 2B). Almost 
all masked hypertension and uncontrolled hypertension 
(96.7% and 94.9%, respectively) showed high morning BP 
(>135/85 mm Hg), whereas only 76.2% of masked hyperten-
sion and 79% of uncontrolled hypertension showed high ev-
ening BP (>135/85 mm Hg) (Fig. 2C).
Comparing office BP in both groups, both systolic and di-
astolic BP was higher in the patients with MH despite compar-
able pulse rate. When analyzing home BP, morning systolic 
and diastolic BP, evening systolic BP, average systolic and di-
astolic BP were significantly higher in the MH group. But, 
when calculating the BP difference of the two groups, the mo-
rning BP difference was significantly higher than the eve-
ning BP difference (Table 4). Comparing home BP profile 
between the MH and non-MH groups in the subgroup of 
controlled hypertension, white-coat hypertension, masked hy-
pertension and uncontrolled hypertension revealed results 
were similar to the previous findings (Supplementary appen-
dix 1). 
If we set up the goal of controlling BP as a BP <140/90 mm Hg 
in the office <135/85 mm Hg at home, significantly fewer MH 
subjects than non-MH subjects achieved the office target 
Table 2. The prevalence of metabolic syndrome and each metabolic component in patient with or without morning hypertension
N (%) Patients with MH (n=173) Patients without MH (n=914) p OR (95% CI)
Metabolic syndrome 097 (59.5) 415 (49.5) 0.019 1.50 (1.07-2.11)
Waist circumference 108 (62.4) 551 (60.4) 0.608 1.09 (0.78-1.53)
IFG+DM 064 (37.4) 258 (28.8) 0.024 1.48 (1.05-2.09)
Triglyceride 061 (37.2) 281 (33.5) 0.360 1.18 (0.83-1.67)
HDL-C 055 (34.2) 268 (32.1) 0.601 1.10 (0.77-1.57)
Hypertension 173 (100.0) 914 (100.0)
MH: morning hypertension, OR: odds ratio, CI: confidence interval, IFG: impaired fasting glucose, DM: diabetes mellitus, HDL-C: high 
density lipoprotein-cholesterol
Fig. 1. The number of metabolic components in patients with morn-
ing hypertension showed increasing tendency (p=0.049). *The 
peak incidence in morning hypertensives was higher.
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(28.9% vs. 53.3%, respectively) and the home target (32.9% vs. 
67.1%, respectively) (Supplementary appendix 2). Similar re-
sults were observed in the diabetic subset of subjects. 
Discussion
Morning rise of BP, high morning BP itself and the differ-
ence of morning-evening BP have been noted as predictors of 
target organ damage and cardiovascular events. As there is no 
consensus of home BP levels for the definition of hyperten-
sion, we used the cut-off values (≥135/85 mm Hg) for MH 
as proposed by the American Hypertension Society
22) and 
added the significance of morning-evening BP difference 
(≥10 mm Hg). 
We demonstrated that MH detected by home BP moni-
toring was related to old age, higher proportion of male and 
greater consumption of alcohol, similar to previous stud-
ies.
15-17) MH was related to perilous clinical variables such as 
higher waist circumference, waist-to-hip ratio and IFG. Pa-
tients with MH had more major cardiovascular risk factors, 
Morning BP ≥135/85 Evening BP ≥135/85
Fig. 2. The distribution of hypertensive patients is significantly different. A: the patients with morning hypertension showed higher prevalence of 
uncontrolled hypertension and masked hypertension and lower prevalence of controlled hypertension compared with the patients without morn-
ing hypertension. B: morning hypertension occupying much higher proportion in masked hypertension and uncontrolled hypertension. C: in the 
patients with masked hypertension or uncontrolled hypertension, there was a tendency to have high morning blood pressure. HT: hypertension.
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Table 3. Major risk factors of cardiovascular disease in patients with or without morning hypertension
N (%) Patients with MH (n=173) Patients without MH (n=914) p OR (95% CI)
Age (M ≥45 years, F ≥55 years) 140 (80.9) 663 (72.5) 0.021 1.59 (1.14-2.21)
Smoking 028 (16.4) 125 (13.7) 0.364 1.23 (0.79-1.92)
Obesity 124 (71.7) 620 (68.0) 0.337 1.19 (0.83-1.71)
Physical inactivity 061 (35.3) 330 (36.1) 0.824 0.96 (0.69-1.35)
FHx of premature CVD 014 (8.1) 089 (9.8) 0.475 0.81 (0.45-1.45)
DM 031 (18.0) 147 (16.2) 0.564 1.13 (0.74-1.74)
Dyslipidemia 074 (43.0) 361 (40.0) 0.456 1.13 (0.82-1.58)
MH: morning hypertension, OR: odds ratio, CI: confidence interval, FHx: family history, CVD: cardiovascular disease, DM: diabetes mellitus738   Morning Hypertension
higher prevalence of metabolic syndrome, higher BP profiles 
and took more drugs for BP control. These observations are 
consistent with a potential relationship of MH and poor car-
diovascular outcome. In the 2007 ESH-ESC practice guide-
lines for the management of arterial hypertension, it was 
opined that all patients should be classified not only in rela-
tion to the grades of hypertension but also in terms of the to-
tal cardiovascular risk resulting from the coexistence of dif-
ferent risk factors, organ damage and disease.
23) The guide-
lines defined the factors influencing prognosis as including 
age (male >55 years, female >65 years), smoking, dyslipid-
emia, IFG and abdominal obesity. Patients with metabolic 
syndrome, target organ damage or DM were regarded as hav-
ing three or more risk factors, which indicated at least a mod-
erate-to-high added risk even in normotensives. In our study, 
the patients with MH had these risk factors more frequently 
and the prevalence of metabolic syndrome was higher. That 
means MH should be treated more aggressively. Therefore, 
MH could be a new therapeutic target for preventing target 
organ damage and subsequent cardiovascular events in hy-
pertensive patients. 
When we calculated the BP difference between MH and 
non-MH subjects, morning BP difference was significantly hi-
gher than evening BP difference in the former. The difference 
of average home BP between the two groups was mainly due 
to the morning BP difference and not the evening BP differ-
ence. In the subgroup analysis of controlled hypertension, the 
MH group displayed a higher average home BP, although it 
was within the normal range. The morning BP difference 
was expected, despite comparable office BP. In this study, 
30.2% of uncontrolled hypertension and 23.1% of masked 
hypertension involved MH subjects, whereas only 5.5% of 
subjects with controlled hypertension had MH. These ob-
servations likely reflect the fact that the home BP of the pa-
tients with MH had been relatively poorly controlled. Put 
another way, MH carries a greater likelihood of masked hy-
pertension or uncontrolled hypertension, attributable to mo-
rning BP difference despite comparable evening BP. 
These observations indicate that although several guide-
lines recommended that home BP should be measured both 
in the morning and in the evening,
24) if it is difficult to mea-
sure BP twice per day, morning BP is likely more informative 
than evening BP. As is apparent in Fig. 2C, scrutiny of only 
evening BP could miss an appreciable portion of cases of un-
controlled hypertension (21%) and masked hypertension 
(24%). But, measuring BP once daily in the morning detects 
95% of uncontrolled hypertension and 97% of masked hy-
pertension. These results clearly indicate that, if it is impos-
sible to check BP twice a day, BP measurement should be per-
formed in the morning. Of course, MH subjects might have 
more cardiovascular risk factors as a result of their poorly 
controlled BP, but the fact that masked hypertension and 
uncontrolled hypertension, which have poor cardiovascular 
outcome, are more frequent in MH, is important per se. 
Defining evening hypertension as a difference in systolic 
or diastolic BP between morning and evening of >10 mm Hg 
with the condition that the evening BP is ≥135/85 mm Hg, 
reveals that, similar to MH, subjects with evening hyperten-
sion less frequently display uncontrolled hypertension than 
MH (44.0% vs. 51.4%), and do not show significant differ-
ence in cardiovascular risk factors that tend to be more fre-
quent in MH (e.g., higher waist circumference, waist-to-hip 
ratio, more frequent IFG, metabolic syndrome and use of 
more antihypertensive medications) compared to non-eve-
ning hypertension group.
The management of hypertension guided by the morning 
Table 4. Office BP measured by doctor and self-measured home BP profile
Patients with MH (n=173) Patients without MH (n=914) BP difference
Office BP 
Systolic BP/Diastolic BP (mm Hg) 144.6±16.1*/86.4±11.9* 137.4±15.6/81.9±10.0
pulse rate (/min) 71.9±11.6 71.4±10.1
Home BP 
Morning BP 
    Systolic BP/Diastolic BP (mm Hg) 145.1±13.3*/88.4±9.8* 127.3±12.15/79.6±8.96 17.8/8.8
    Pulse rate (/min) 65.9±9.1 65.5±7.8
Evening BP 
    Systolic BP Diastolic BP (mm Hg) 129.8±13.6*/78.4±9.4 126.8±13.5/77.2±9.7 3.0/1.2
    Pulse rate (/min) 68.2±9.4 67.6±8.3
Average home BP 
    Systolic BP/Diastolic BP (mm Hg) 137.5±12.5*/83.4±9.1* 127.0±12.2/78.4±9.1 10.5/5.0
    Pulse rate (/min) 67.0±8.9 66.6±7.7
Mean±SD. *p<0.05 when compared to the patients without MH. MH: morning hypertension, BP: blood pressure, BP difference, (blood pres-
sure value of the patients with morning hypertension)-(blood pressure value of the patients without morning hypertension)Ju-Hee Lee, et al.   739
BP level might achieve an additional benefit by modifying 
cardiovascular risk. Morning BP should be monitored at 
home as a first step in the treatment of hypertension and the 
needs for more effective, long-acting antihypertensive thera-
py or drug prescriptions that consider pharmacokinetics and 
chronobiology can be magnified.
In this study, even among well-controlled hypertensives, 
10.8% (46 patients) showed high morning BP (≥135/85 mm Hg). 
Several recent studies reported that patients with or without 
hypertension had the same 24-hour pattern of onset of car-
diovascular events.
2)3) These data strengthen the suggestion 
that high BP in the morning may also be harmful for normo-
tensive subjects, and that MH may be crucial in cardiovascu-
lar events irrespective of the existence of hypertension. An 
accurate evaluation of MH and its treatment might be useful 
for controlled hypertensives as well, so morning BP should 
be monitored to diagnose undetected MH even in hyperten-
sives who appear to be well-controlled in the clinic. 
The cross-sectional and observational nature of our study 
imposed limitations. The study findings were insufficient to 
clarify whether MH is a unique form of hypertension or a 
consequence of undertreatment. Although the participants 
had been on a stable antihypertensive medication without any 
change for at least for 6 months and data on prescribed drug 
classes were available, we could not obtain a specific drug reg-
imen considering a chronobiological effect (administered 
doses or dosing schedules). So, there is the possibility of a con-
founding effect of anti-hypertensive medications. Elevated 
morning BP level includes two different types of BP variation: 
nocturnal hypertension (such as non-dippers) and morning 
surge type.
25) We could not distinguish between these types 
using conventional home BP devices. In this study, we could 
not prove the direct inter-relationship between MH and CV 
risk or TOD, maybe due to the relatively short follow-up pe-
riod. The patients with MH were related to worse prognostic 
factors, but they could not be generalized to worsened car-
diovascular outcome in the absence of long-term clinical fol-
low-up and event analysis in our data. Despite the large num-
ber of participants, it is difficult to generalize the present find-
ings to the general population, because this study was con-
ducted in a hospital-based manner. 
Conclusion
MH in treated hypertensives is more likely seen among 
patients who are male, older and more often consume alco-
hol. MH is related to worsened clinical variables such as hi-
gher waist circumference, higher waist-to-hip ratio, IFG and 
higher BP. So, a potential relationship of MH and poor car-
diovascular outcome can be suggested. Home BP monitor-
ing is essential for the treatment of hypertension and the pa-
tients with MH should be treated more vigorously for pre-
venting unfavorable cardiovascular outcome in the future. 
Conduction of a large sized longer clinical follow-up trial is 
essential to clarify the clinical significance of MH. 
Acknowledgments
This work was supported by the research grant of the Chungbuk Na-
tional University in 2009.
REFERENCES
1) Manfredini R, Gallerani M, Portaluppi F, Fersini C. Relationships of 
the circadian rhythms of thrombotic, ischemic, hemorrhagic, and ar-
rhythmic events to blood pressure rhythms. Ann N Y Acad Sci 1996; 
783:141-58.
2) Giles TD. Circadian rhythm of blood pressure and the relation to 
cardiovascular events. J Hypertens Suppl 2006;24:S11-6.
3) Ohkubo T, Imai Y, Tsuji I, et al. Prediction of mortality by ambulatory 
blood pressure monitoring versus screening blood pressure measure-
ments: a pilot study in Ohasama. J Hypertens 1997;15:357-64.
4) Asayama K, Ohkubo T, Kikuya M, et al. Prediction of stroke by home 
“morning” versus “evening” blood pressure values: the Ohasama 
Study. Hypertension 2006;48;737-43.
5) Kario K, Ishikawa J, Pickering TG, et al. Morning hypertension: the 
strongest independent risk factor for stroke in elderly hypertensive 
patients. Hypertens Res 2006;29:581-7.
6) Kario K, Pickering TG, Umeda Y, et al. Morning surge in blood pres-
sure as a predictor of silent and clinical cerebrovascular disease in el-
derly hypertensives: a prospective study. Circulation 2003;107:1401-6.
7) Gosse P, Cipriano C, Bemurat L, et al. Prognostic significance of 
blood pressure measured on rising. J Hum Hypertens 2001;15:413-7.
8) Gosse P, Lasserre R, Minifié C, Lemetayer P, Clementy J. Blood pre-
ssure surge on rising. J Hypertens 2004;22:1113-8.
9) Polónia J, Amado P, Barbosa L, et al. Morning rise, morning surge and 
daytime variability of blood pressure and cardiovascular target organ 
damage: a cross-sectional study in 743 subjects. Rev Port Cardiol 
2005;24:65-78.
10) Marfella R, Siniscalchi M, Nappo F, et al. Regression of carotid ath-
erosclerosis by control of morning blood pressure peak in newly diag-
nosed hypertensive patients. Am J Hypertens 2005;18:308-18.
11) Ikeda T, Gomi T, Shibuya Y, et al. Morning rise in blood pressure is 
a predictor of left ventricular hypertrophy in treated hypertensive pa-
tients. Hypertens Res 2004;27:939-46.
12) Shibuya Y, Ikeda T, Gomi T. Morning rise of blood pressure assessed 
by home blood pressure monitoring is associated with left ventricular 
hypertrophy in hypertensive patients receiving long-term antihyper-
tensive medication. Hypertens Res 2007;30:903-11.
13) Ishikawa J, Hoshide S, Shibasaki S, et al. Relationship between morn-
ing hypertension identified by home blood pressure monitoring and 
brain natriuretic peptide and estimated glomerular filtration rate: the 
Japan Morning Surge 1 (JMS-1) Study. J Clin Hypertens (Greenwich) 
2008;10:34-42.
14) Kamoi K, Miyakoshi M, Soda S, Kaneko S, Nakagawa O. Usefulness 
of home blood pressure measurement in the morning in type 2 diabetic 
patients. Diabetes Care 2002;25:2218-23.
15) Ishikawa J, Kario K, Eguchi K, et al. Regular alcohol drinking is a de-
terminant of masked morning hypertension detected by home blood 
pressure monitoring in medicated hypertensive patients with well-
controlled clinic blood pressure: the Jichi Morning Hypertension 
Research (J-MORE) Study. Hypertens Res 2006;29:679-86.
16) Ishikawa J, Kario K, Hoshide S, et al. Determinants of exaggerated 
difference in morning and evening blood pressure measured by self-
measured blood pressure monitoring in medicated hypertensive pa-
tients: Jichi Morning Hypertension Research (J-MORE) Study. Am J 
Hypertens 2005;18:958-65.
17) Kawabe H, Saito I. Determinants of exaggerated difference in morn-
ing and evening home blood pressure in Japanese normotensives. Hy-
pertens Res 2009;32:1028-31.740   Morning Hypertension
18) Tamaki S, Nakamura Y, Yoshino T, et al. The association between mo-
rning hypertension and metabolic syndrome in hypertensive patients. 
Hypertens Res 2006;29:783-8.
19) Shimizu M, Ishikawa J, Eguchi K, Hoshide S, Shimada K, Kario K. As-
sociation of an abnormal blood glucose level and morning blood pres-
sure surge in elderly subjects with hypertension. Am J Hypertens 2009; 
22:611-6.
20) Imai Y, Otsuka K, Kawano Y, et al. Japanese society of hypertension 
(JSH) guidelines for self-monitoring of blood pressure at home. Hy-
pertens Res 2003;26:771-82.
21) Lim S, Lee EJ, Koo BK, et al. Increasing trends of metabolic syn-
drome in Korea-based on Korean National Health and Nutrition Ex-
amination Surveys. J Korean Diabetes Assoc 2005;29:432-9.
22) Pickering T. Recommendations for the use of home (self) and ambula-
tory blood pressure monitoring: American Society of Hypertension 
Ad Hoc Panel. Am J Hypertens 1996;9:1-11.
23) Mancia G, De Backer G, Dominiczak A, et al. 2007 ESH-ESC Prac-
tice Guidelines for the Management of Arterial Hypertension: ESH-
ESC Task Force on the Management of Arterial Hypertension. J Hy-
pertens 2007;25:1751-62.
24) Mengden T, Chamontin B, Phong Chau N, Luis Palma Gamiz J, 
Chanudet X. User procedure for self-measurement of blood pressure: 
First International Consensus Conference on Self Blood Pressure 
Measurement. Blood Press Monit 2000;5:111-29. 
25) Kario K, White WB. Early morning hypertension: what does it con-
tribute to overall cardiovascular risk assessment? J Am Soc Hyper-
tens 2008;2:397-402.Ju-Hee Lee, et al.   741
A: BP profiles in controlled hypertension
Patients with MH (n=23) Patients without MH (n=392) p BP difference
Clinic BP (mm Hg) 
    Systolic BP 124.6±10.74 125.5±9.27 0.663
    Diastolic BP 76.2±8.22 076.2±7.44 0.994
Home BP (mm Hg) 
    Morning BP 
        Systolic BP 135.6±7.430 120.2±8.06 <0.001 15.4
        Diastolic BP 83.8±8.08 075.2±6.61 <0.001 8.6
    Evening BP
        Systolic BP 116.7±12.44 118.0±8.22 0.458 -1.3
        Diastolic BP 71.7±5.68 072.4±7.28 0.687 -0.7
    Average home
        Systolic BP 126.1±7.520 119.1±7.46 <0.001 7.0
        Diastolic BP 77.8±5.16 073.8±6.52 0.004 4.0
Mean±SD. MH: morning hypertension, BP: blood pressure, BP difference, (blood pressure value of the patients with morning hypertension)-
(blood pressure value of the patients without morning hypertension)
B: BP profiles in white-coat hypertension
Patients with MH (n=34) Patients without MH (n=221) p BP difference
Clinic BP (mm Hg) 
    Systolic BP 147.8±9.64 149.3±10.38 0.420
    Diastolic BP 0090.4±11.09 85.5±8.50 0.003
Home BP (mm Hg)  
    Morning BP 
        Systolic BP 138.3±8.51 124.0±7.000 <0.001 14.3
        Diastolic BP 081.3±7.85 76.5±6.29 <0.001 4.8
    Evening BP 
        Systolic BP 119.0±5.76 123.4±8.120 <0.001 -4.4
        Diastolic BP 071.2±9.20 73.9±6.68 0.113 -2.7
    Average home BP 
        Systolic BP 128.7±4.30 123.7±6.600 <0.001 5.0
        Diastolic BP 076.2±8.12 75.2±6.15 0.377 1.0
Mean±SD. MH: morning hypertension, BP: blood pressure, BP difference, (blood pressure value of the patients with morning hypertension)-
(blood pressure value of the patients without morning hypertension)
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C: BP profiles in masked hypertension
Patients with MH (n=27) Patients without MH (n=95) p BP difference
Clinic BP (mm Hg) 
    Systolic BP 130.5±7.470 130.3±7.360 0.898
    Diastolic BP 76.9±8.32 79.9±7.32 0.074
Home BP (mm Hg) 
    Morning BP 
        Systolic BP 146.6±10.20 136.4±8.460 <0.001 10.2
        Diastolic BP 89.6±6.99 87.1±6.83 0.098 2.5
    Evening BP
        Systolic BP 132.7±7.110 138.2±10.38 0.002 -5.5
        Diastolic BP 80.9±4.33 85.7±7.70 <0.001 -4.8
    Average home
        Systolic BP 139.6±8.270 137.3±8.540 0.211 2.3
        Diastolic BP 85.3±5.27 86.4±6.93 0.436 -1.1
Mean±SD. MH: morning hypertension, BP: blood pressure, BP difference, (blood pressure value of the patients with morning hypertension)-
(blood pressure value of the patients without morning hypertension)
D: BP profiles in uncontrolled hypertension
Patients with MH (n=89) Patients without MH (n=206) p BP difference
Clinic BP (mm Hg) 
    Systolic BP 152.8±13.61 150.5±12.55 0.152
    Diastolic BP 090.5±10.67 90.1±9.63 0.778
Home BP (mm Hg) 
    Morning BP 
        Systolic BP 149.7±14.54 140.2±11.59 <0.001 9.7
        Diastolic BP 92.0±9.86 87.9±8.22 <0.001 4.1
    Evening BP
        Systolic BP 136.5±12.48 141.8±10.58 <0.001 -5.3
        Diastolic BP 82.2±8.82 86.2±8.51 <0.001 -4.0
    Average home
        Systolic BP 143.1±12.87 141.0±10.15 0.136 2.1
        Diastolic BP 87.1±8.93 87.1±8.03 1.000 0.0
Mean±SD. MH: morning hypertension, BP: blood pressure, BP difference, (blood pressure value of the patients with morning hypertension)-
(blood pressure value of the patients without morning hypertension)Ju-Hee Lee, et al.   743
A: Patients achieving BP goals
Patients with MH Patients without MH
Clinic BP, n (%)*
    <140/90 mm Hg  050 (28.9) 487 (53.3)
    ≥140/90 mm Hg  123 (71.1) 427 (46.7)
Home BP, n (%)†
    <135/85 mm Hg  057 (32.9) 613 (67.1)
    ≥135/85 mm Hg  116 (67.1) 301 (32.9)
*p<0.001, OR=2.81 (95% CI 1.970-3.995), †p<0.001, OR=4.15 (95% 
CI 2.933-5.856). BP: blood pressure, MH: morning hypertension
B: Patients achieving BP goals in DM patients
Patients with MH Patients without MH
Clinic BP, n (%)*
    <130/80 mm Hg  2 (6.5) 036 (24.5)
    ≥130/80 mm Hg  29 (93.5) 111 (75.5)
Home BP, n (%)†
    <130/80 mm Hg  04 (12.9) 059 (40.1)
    ≥130/80 mm Hg  27 (87.1) 088 (59.9)
*p=0.026, OR=4.70 (95% CI 1.069-20.687), †p=0.004, OR=4.53 (95% 
CI 1.505-13.604). BP: blood pressure, MH: morning hypertension
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